Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 103

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Accurate de novo design of high-affinity protein-binding macrocycles using deep learning

Rettie, Stephen A., Juergens, David, Adebomi, Victor, Bueso, Yensi Flores, Zhao, Qinqin, Leveille, Alexandria N., Liu, Andi, Bera, Asim K., Wilms, Joana A., Üffing, Alina, Kang, Alex, Brackenbrough, Evans, Lamb, Mila, Gerben, Stacey R., Murray, Analisa, Levine, Paul M., Schneider, Maika, Vasireddy, Vibha, Ovchinnikov, Sergey, Weiergräber, Oliver H., Willbold, Dieter, Kritzer, Joshua A., Mougous, Joseph D., Baker, David, DiMaio, Frank, Bhardwaj, Gaurav·2025·Nature Chemical Biology

Abstract

Developing macrocyclic binders to therapeutic proteins typically relies on large-scale screening methods that are resource intensive and provide little control over binding mode. Despite progress in protein design, there are currently no robust approaches for de novo design of protein-binding macrocycles. Here we introduce RFpeptides, a denoising diffusion-based pipeline for designing macrocyclic binders against protein targets of interest. We tested 20 or fewer designed macrocycles against each of four diverse proteins and obtained binders with medium to high affinity against all targets. For one of the targets, Rhombotarget A (RbtA), we designed a high-affinity binder ( K d < 10 nM) despite starting from the predicted target structure. X-ray structures for macrocycle-bound myeloid cell leukemia 1, γ-aminobutyric acid type A receptor-associated protein and RbtA complexes match closely with the computational models, with a Cα root-mean-square deviation < 1.5 Å to the design models. RFpeptides provides a framework for rapid and custom design of macrocyclic peptides for diagnostic and therapeutic applications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41589-025-01929-w

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Research works printed but not linked: 43

  1. Vinogradov, A. A., Yin, Y. & Suga, H. Macrocyclic peptides as drug candidates: recent progress and remaining challenges. J. Am. Chem. Soc. 141, 4167–4181 (2019). · DOI · Paper page
  2. Muttenthaler, M., King, G. F., Adams, D. J. & Alewood, P. F. Trends in peptide drug discovery. Nat. Rev. Drug Discov. 20, 309–325 (2021). · DOI · Paper page
  3. Tsomaia, N. Peptide therapeutics: targeting the undruggable space. Eur. J. Med. Chem. 94, 459–470 (2015). · DOI · Paper page
  4. Atanasov, A. G., Zotchev, S. B. & Dirsch, V. M. International Natural Product Sciences Taskforce & Supuran, C. T. Natural products in drug discovery: advances and opportunities. Nat. Rev. Drug Discov. 20, 200–216 (2021). · DOI · Paper page
  5. Bhardwaj, G. et al. Accurate de novo design of membrane-traversing macrocycles. Cell 185, 3520–3532 (2022). · DOI · Paper page
  6. Bhardwaj, G. et al. Accurate de novo design of hyperstable constrained peptides. Nature 538, 329–335 (2016). · DOI · Paper page
  7. Hosseinzadeh, P. et al. Comprehensive computational design of ordered peptide macrocycles. Science 358, 1461–1466 (2017). · DOI · Paper page
  8. Mulligan, V. K. et al. Computationally designed peptide macrocycle inhibitors of New Delhi metallo-β-lactamase 1. Proc. Natl Acad. Sci. USA 118, e2012800118 (2021). · DOI
  9. Hosseinzadeh, P. et al. Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites. Nat. Commun. 12, 3384 (2021). · DOI · Paper page
  10. Muratspahić, E. et al. Design and structural validation of peptide–drug conjugate ligands of the κ-opioid receptor. Nat. Commun. 14, 8064 (2023). · DOI
  11. Rettie, S. A. et al. Cyclic peptide structure prediction and design using AlphaFold2. Nat. Commun. 16, 4730 (2025). · DOI · Paper page
  12. Grambow, C. A., Weir, H., Cunningham, C. N., Biancalani, T. & Chuang, K. V. CREMP: conformer–rotamer ensembles of macrocyclic peptides for machine learning. Sci. Data 11, 859 (2024). · DOI
  13. Zhang, C. et al. HighFold: accurately predicting structures of cyclic peptides and complexes with head-to-tail and disulfide bridge constraints. Brief. Bioinform 25, bbae215 (2024). · DOI
  14. Brixi, G. et al. SaLT&PepPr is an interface-predicting language model for designing peptide-guided protein degraders. Commun. Biol. 6, 1081 (2023). · DOI
  15. Xie, X., Valiente, P. A., Kim, J. & Kim, P. M. HelixDiff, a score-based diffusion model for generating all-atom α-helical structures. ACS Cent. Sci. 10, 1001–1011 (2024). · DOI
  16. Li, Q., Vlachos, E. N. & Bryant, P. Design of linear and cyclic peptide binders of different lengths from protein sequence information. Preprint at bioRxiv https://doi.org/10.1101/2024.06.20.599739 (2024). · DOI
  17. Vázquez Torres, S. et al. De novo design of high-affinity binders of bioactive helical peptides. Nature 626, 435–442 (2024). · DOI · Paper page
  18. Wicky, B. I. M. et al. Hallucinating symmetric protein assemblies. Science 378, 56–61 (2022). · DOI · Paper page
  19. Widden, H. & Placzek, W. J. The multiple mechanisms of MCL1 in the regulation of cell fate. Commun. Biol. 4, 1029 (2021). · DOI · Paper page
  20. Leman, J. K. et al. Macromolecular modeling and design in Rosetta: recent methods and frameworks. Nat. Methods 17, 665–680 (2020). · DOI · Paper page
  21. Brown, H. et al. Structure-based design of stapled peptides that bind GABARAP and inhibit autophagy. J. Am. Chem. Soc. 144, 14687–14697 (2022). · DOI
  22. Ji, C. H. et al. The AUTOTAC chemical biology platform for targeted protein degradation via the autophagy–lysosome system. Nat. Commun. 13, 904 (2022). · DOI · Paper page
  23. Popelka, H. & Klionsky, D. J. Analysis of the native conformation of the LIR/AIM motif in the Atg8/LC3/GABARAP-binding proteins. Autophagy 11, 2153–2159 (2015). · DOI
  24. Weiergräber, O. H. et al. Ligand binding mode of GABAA receptor-associated protein. J. Mol. Biol. 381, 1320–1331 (2008). · DOI
  25. van der Maaten, L. & Hinton, G. Visualizing data using t-SNE. J. Mach. Learn. Res. 9, 2579–2605 (2008).
  26. Pedregosa, F. et al. Scikit-learn: machine learning in Python. J. Mach. Learn. Res. 12, 2825–2830 (2011).
  27. Zhang, Y. & Skolnick, J. TM-align: a protein structure alignment algorithm based on the TM-score. Nucleic Acids Res 33, 2302–2309 (2005). · DOI · Paper page
  28. Dauparas, J. et al. Atomic context-conditioned protein sequence design using LigandMPNN. Nat. Methods 22, 717–723 (2025). · DOI · Paper page
  29. Siew, N., Elofsson, A., Rychlewski, L. & Fischer, D. MaxSub: an automated measure for the assessment of protein structure prediction quality. Bioinformatics 16, 776–785 (2000). · DOI · Paper page
  30. Fire, E., Gullá, S. V., Grant, R. A. & Keating, A. E. Mcl‐1–Bim complexes accommodate surprising point mutations via minor structural changes. Protein Sci. 19, 507–519 (2010). · DOI
  31. Anil, B., Riedinger, C., Endicott, J. A. & Noble, M. E. M. The structure of an MDM2–Nutlin-3a complex solved by the use of a validated MDM2 surface-entropy reduction mutant. Acta Crystallogr. D 69, 1358–1366 (2013). · DOI
  32. Sumida, K. H. et al. Improving protein expression stability and function with ProteinMPNN. J. Am. Chem. Soc. 146, 2054–2061 (2024). · doi:10.1021/jacs.3c10941
  33. Davis, G. D., Elisee, C., Newham, D. M. & Harrison, R. G. New fusion protein systems designed to give soluble expression in Escherichia coli. Biotechnol. Bioeng 65, 382–388 (1999). · DOI · Paper page
  34. Dang, B. et al. SNAC-tag for sequence-specific chemical protein cleavage. Nat. Methods 16, 319–322 (2019). · DOI
  35. Vagin, A. & Teplyakov, A. Molecular replacement with MOLREP. Acta Crystallogr. D 66, 22–25 (2010). · DOI · Paper page
  36. Vagin, A. & Lebedev, A. MoRDa, an automatic molecular replacement pipeline. Acta Crystallogr. A Found. Adv. 71, s19 (2015). · DOI · Paper page
  37. Liebschner, D. et al. Macromolecular structure determination using X-rays neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D Struct. Biol. 75, 861–877 (2019). · DOI · Paper page
  38. Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486–501 (2010). · DOI · Paper page
  39. Williams, C. J. et al. MolProbity: more and better reference data for improved all‐atom structure validation. Protein Sci. 27, 293–315 (2018). · DOI · Paper page
  40. McCoy, A. J. et al. Read Phaser crystallographic software. J. Appl. Crystallogr. 40, 658–674 (2007). · DOI · Paper page
  41. Leveille, A. N. et al. Exploring arylidene–indolinone ligands of autophagy proteins LC3B and GABARAP. ACS Med. Chem. Lett. 16, 271–277 (2025). · DOI
  42. Hunter, J. D. Matplotlib: a 2D graphics environment. Comput. Sci. Eng 9, 90–95 (2007). · DOI · Paper page
  43. Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci 30, 70–82 (2021). · DOI · Paper page

Metadata

Authors
Rettie, S. A., Juergens, D., Adebomi, V., Bueso, Y. F., Zhao, Q., Leveille, A. N., Liu, A., Bera, A. K., Wilms, J. A., Üffing, A., Kang, A., Brackenbrough, E., Lamb, M., Gerben, S. R., Murray, A., Levine, P. M., Schneider, M., Vasireddy, V., Ovchinnikov, S., Weiergräber, O. H., Willbold, D., Kritzer, J. A., Mougous, J. D., Baker, D., DiMaio, F., & Bhardwaj, G.
Venue
Nature Chemical Biology
Published
2025-06-20
Volume
21
Issue
12
Pages
1948-1956
ISSN
  • 1552-4450
  • 1552-4469
Cited by
103
References
13
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Accurate de novo design of high-affinity protein-binding macrocycles using deep learning. https://app.cochat.ai/papers/10.1038/s41589-025-01929-w
The paper
Rettie, S. A., Juergens, D., Adebomi, V., Bueso, Y. F., Zhao, Q., Leveille, A. N., Liu, A., Bera, A. K., Wilms, J. A., Üffing, A., Kang, A., Brackenbrough, E., Lamb, M., Gerben, S. R., Murray, A., Levine, P. M., Schneider, M., Vasireddy, V., Ovchinnikov, S., . . . Bhardwaj, G. (2025). Accurate de novo design of high-affinity protein-binding macrocycles using deep learning. Nature Chemical Biology. https://doi.org/10.1038/s41589-025-01929-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.